X4 Pharmaceuticals Inc (XFOR)
0.2743
-0.32
(-53.67%)
USD |
NASDAQ |
Nov 13, 16:00
0.2957
+0.02
(+7.80%)
After-Hours: 20:00
X4 Pharmaceuticals Price to Book Value: 0.4893 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.4893 |
| November 12, 2024 | 1.056 |
| November 11, 2024 | 1.183 |
| November 08, 2024 | 1.102 |
| November 07, 2024 | 1.100 |
| November 06, 2024 | 1.033 |
| November 05, 2024 | 0.9923 |
| November 04, 2024 | 0.9485 |
| November 01, 2024 | 0.9259 |
| October 31, 2024 | 0.8924 |
| October 30, 2024 | 0.9259 |
| October 29, 2024 | 0.8875 |
| October 28, 2024 | 0.892 |
| October 25, 2024 | 0.867 |
| October 24, 2024 | 0.8643 |
| October 23, 2024 | 0.8998 |
| October 22, 2024 | 0.9013 |
| October 21, 2024 | 0.8849 |
| October 18, 2024 | 0.9268 |
| October 17, 2024 | 0.8861 |
| October 16, 2024 | 0.9509 |
| October 15, 2024 | 0.9933 |
| October 14, 2024 | 0.9953 |
| October 11, 2024 | 0.9129 |
| October 10, 2024 | 0.9346 |
| Date | Value |
|---|---|
| October 09, 2024 | 0.9473 |
| October 08, 2024 | 0.9651 |
| October 07, 2024 | 0.9432 |
| October 04, 2024 | 1.108 |
| October 03, 2024 | 1.123 |
| October 02, 2024 | 1.087 |
| October 01, 2024 | 1.133 |
| September 30, 2024 | 1.194 |
| September 27, 2024 | 1.168 |
| September 26, 2024 | 1.177 |
| September 25, 2024 | 1.148 |
| September 24, 2024 | 1.277 |
| September 23, 2024 | 1.260 |
| September 20, 2024 | 1.261 |
| September 19, 2024 | 1.262 |
| September 18, 2024 | 1.254 |
| September 17, 2024 | 1.254 |
| September 16, 2024 | 1.182 |
| September 13, 2024 | 1.267 |
| September 12, 2024 | 1.210 |
| September 11, 2024 | 1.227 |
| September 10, 2024 | 1.231 |
| September 09, 2024 | 1.186 |
| September 06, 2024 | 1.162 |
| September 05, 2024 | 1.204 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4893
Minimum
Nov 13 2024
238.29
Maximum
Apr 03 2024
10.63
Average
1.659
Median
Jul 07 2021
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.9398 |
| Theriva Biologics Inc | 0.0551 |
| Oragenics Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 3.048 |
| Price | 0.2743 |
| Earnings Yield | 32.81% |
| Market Cap | 46.22M |